264 filings
Page 11 of 14
8-K
15mfd9d3phd59xlz jxp
14 Nov 19
Eton Pharmaceuticals Announces Third Quarter Financial Results and Highlights Business Progress
12:00am
8-K
z74hv8gsgqr
22 Oct 19
Eton Pharmaceuticals Announces U.S. FDA Approval of Biorphen® (phenylephrine HCI) Injection
7:33am
8-K
op73rgi ynx
19 Aug 19
Eton Pharmaceuticals Announces Positive Results from Clinical Study Report of ET-104
7:28am
4
lti658gf
13 Aug 19
Eton Pharmaceuticals / SEAN BRYNJELSEN ownership change
4:04pm
4
3aizzkybebm5v0cysw
12 Aug 19
Eton Pharmaceuticals / CHARLES J CASAMENTO ownership change
4:17pm
8-K
u3rb3heioh 9de0ik1h
6 Aug 19
Eton Announces Second Quarter Financial Results and Highlights Business Progress
4:20pm
8-K
fzdqd43dkjqxrysbnm
1 Aug 19
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-105
8:21am
8-K
ibwozs z907inj
12 Jul 19
Eton Pharmaceuticals Provides Update on EM-100 Program
4:48pm
8-K
c3784m t7v
13 Jun 19
Eton Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application and Provides Pipeline Update
4:12pm
8-K
9booyt5 upj
12 Jun 19
Submission of Matters to a Vote of Security Holders
5:28pm
SC 13G
im19edm
24 May 19
Eton Pharmaceuticals, Inc.
5:20pm
4
ahgyoai ii6jm
22 May 19
Eton Pharmaceuticals / SEAN BRYNJELSEN ownership change
4:25pm
8-K
qkc2jo74jio sznxxbll
7 May 19
Eton Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Business Progress
4:12pm
DEFA14A
ovwewm1nng7oad
26 Apr 19
Additional proxy soliciting materials
4:36pm
DEF 14A
d4c3iwn
26 Apr 19
Definitive proxy
4:34pm
S-8
9lei1jf
28 Mar 19
Registration of securities for employees
4:24pm
10-K
3ffe18dt
25 Mar 19
Annual report
9:31am